SRPTSarepta Therapeutics, Inc. ·Congress trades
Price as of 8:20 PM ET3 members of Congress and 1 executive-branch official have disclosed 11 trades in $SRPT.
The latest was disclosed on Sep 22, 2026: a sale by Donald Trump, made on Jul 29, 2026. The biggest were 5 trades of up to $50K each, the newest a sale by Donald Trump, made on Jul 29, 2026.
$16.07
▼ $2.74 (14.57%)Past year
$24.55$14.14
Nov ’25Feb ’26May ’26Aug ’26Nov ’26
BuySaledots mark the days politicians bought or sold it; days close together share a dot
11
congress trades
up to$340K
disclosed volume
4 / 7
buys / sells
4
politicians trading
Who's trading $SRPT
Biggest disclosed buyers first
Amounts are the top of each disclosed range, added up. Every trade below links to its filing.
Congressional trades in SRPT
Sell$15K–$50K- Sell$15K–$50K
- Sell$1K–$15K
- Buy$15K–$50K
Sell$1K–$15K
Buy$1K–$15K- Sell$1K–$15K
Sell$15K–$50K- Buy$15K–$50K
- Buy$1K–$15K
- Sell$1K–$15K
| Politician | Type | Amount | Traded | Disclosed | Filing |
|---|---|---|---|---|---|
| Donald J. TrumpR· US | Sell | $15K–$50K | Jul 29, 2026 | 1 mo ago | Filing ↗ |
| Donald J. TrumpR· US | Sell | $15K–$50K | Jun 4, 2026 | 2 mo ago | Filing ↗ |
| Donald J. TrumpR· US | Sell | $1K–$15K | Mar 30, 2026 | 6 mo ago | Filing ↗ |
| Donald J. TrumpR· US | Buy | $15K–$50K | Mar 4, 2026 | 6 mo ago | Filing ↗ |
| Gilbert Ray Cisneros, Jr.D· CA-31 | Sell | $1K–$15K | Apr 14, 2025 | 1y ago | Filing ↗ |
| Josh GottheimerD· NJ-5 | Buyjoint | $1K–$15K | Jul 14, 2023 | 3y ago | Filing ↗ |
| Josh GottheimerD· NJ-5 | Selljoint | $1K–$15K | Jun 13, 2023 | 3y ago | Filing ↗ |
| Daniel S. GoldmanD· NY-10 | Sell | $15K–$50K | Apr 10, 2023 | 3y ago | Filing ↗ |
| Daniel S. GoldmanD· NY-10 | Buy | $15K–$50K | Mar 6, 2023 | 3y ago | Filing ↗ |
| Josh GottheimerD· NJ-5 | Buyjoint | $1K–$15K | Mar 6, 2023 | 3y ago | Filing ↗ |
| Daniel S. GoldmanD· NY-10 | Sell | $1K–$15K | Jan 31, 2023 | 3y ago | Filing ↗ |
4 politicians have traded $SRPT
See exactly what they buy the night they file, and copy it in your own brokerage.